Intensive Dose-Dense Compared With Conventionally Scheduled Preoperative Chemotherapy for High-Risk Primary Breast CancerMichael Untch(Helios Hospital Berlin-Buch), Gottfried E. Konecny(Universität Hamburg)Journal of Clinical OncologyApril 14, 200910.1200/jco.2008.20.3133Cited by 151SaveCiteExport RISWatch citationsRelated PapersPembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)|European Journal of Cancer|2023|35